Saint-Julien-l'Ars, France

Brigitte Renoux

This inventor holds 1 USPTO granted patent. Top assignees: Behringwerke Aktiengesellschaft, Laboratoires Hoechst. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Brigitte Renoux. Retrieved from https://idiyas.com/inventor/brigitte-renoux-iravso6i

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 18.0

ph-index = 1

Forward Citations = 44(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Brigitte Renoux: Innovator in Glycosylated Prodrugs

Introduction

Brigitte Renoux is a notable inventor based in Saint-Julien-l'Ars, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of glycosylated prodrugs. Her innovative work has led to the filing of a patent that showcases her expertise and dedication to advancing medical science.

Latest Patents

Brigitte Renoux holds a patent for "Glycosylated prodrugs, their method of preparation and their uses." This patent highlights her innovative approach to drug formulation and delivery, which has the potential to improve therapeutic outcomes for patients.

Career Highlights

Throughout her career, Brigitte has worked with prominent companies in the pharmaceutical industry. She has been associated with Laboratoires Hoechst and Behringwerke Aktiengesellschaft, where she contributed her knowledge and skills to various projects. Her experience in these organizations has helped her refine her expertise in drug development.

Collaborations

Brigitte has collaborated with esteemed colleagues, including Jean-Claude Jacquesy and Jean-Pierre Gesson. These partnerships have allowed her to expand her research and enhance the impact of her work in the field of pharmaceuticals.

Conclusion

Brigitte Renoux is a pioneering inventor whose work in glycosylated prodrugs has made a significant impact on the pharmaceutical industry. Her contributions continue to inspire future innovations in drug development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…